Simmons Hanly Conroy, a national complex litigation firm and one of the country’s leading mesothelioma law firms, is pleased to announce that Moshe Horn has joined the firm’s New York City office as a shareholder to help spearhead the expansion of the firm’s litigation capabilities in asbestos, mass tort and class action practices.
Horn has obtained numerous seven-figure verdicts for his clients and is one of the few lawyers in the country to try a class action case, receiving a $47 million verdict in federal court. Having tried over 100 cases in different jurisdictions in all types of matters, both civil and criminal, he is skilled in the nuances of jury research and selection in both civil and criminal matters.
Moshe was previously a partner at Seeger Weiss LLP and was a member of the trial team that achieved a $47.5 million verdict against Merck for a client’s Vioxx-related injuries. He contributed broadly to the firm’s commercial litigation practice, and handled private criminal and personal injury matters as well.
Moshe began his career at the Manhattan District Attorney’s office, spending 10 years there trying and investigating complex cases. After leaving the DA, Moshe worked at the law firm of Kaye Scholer, focusing on product liability and asbestos defense.
“Moshe is rightfully recognized as one of the nation’s best trial strategists,” said Larry Nassif, managing shareholder of Simmons Hanly Conroy. “As we continue to grow as a firm, I have no doubt his experience will help our clients and continue to hold corporate wrongdoers accountable for their actions.”
Moshe has been an adjunct professor of law at the Benjamin Cardozo School of Law for 25 years teaching courses in trial advocacy, and the business of law, and was selected recently as best adjunct professor. He is a frequent lecturer in the art of jury selection, cross examination, and all other aspects of trying a case. He is also active in the community, coaching youth mock trial teams and an active lecturer in schools, advising students and parent associations on criminal issues facing teens and millennials.
Simmons Hanly Conroy represents more families impacted by mesothelioma — an aggressive form of cancer linked to asbestos exposure — and files more mesothelioma cases every year than any other law firm in the country. The firm has achieved 11 verdicts on behalf of its clients in the past six years.
Additionally, Simmons Hanly Conroy is co-lead in the National Prescription Opiate Multi-District Litigation (Opioid MDL) and at the forefront of numerous cases protecting victims, including the recent investigation on behalf of women who developed uterine cancer after using chemical hair straightener products.
Moshe graduated from George Washington University and earned his law degree from the Benjamin N. Cardozo School of Law.
About Simmons Hanly Conroy
Simmons Hanly Conroy is one of the nation’s largest mass tort law firms, dedicated to helping victims of mesothelioma and asbestos-related cancers. Other primary areas of litigation include prescription opioids, sexual abuse, pharmaceutical, consumer protection, environmental, and personal injury. Firm attorneys have been appointed to leadership in numerous national multidistrict litigations, including prescription opioids, Vioxx, Yaz, and Toyota Unintended Acceleration. The firm also represents small and mid-size corporations, inventors and entrepreneurs in matters involving business litigation. Firm attorneys’ passion for improving the lives of asbestos victims and their families extends to the firm’s contributions to mesothelioma cancer research and ongoing support through initiatives including the firm’s annual Miles for Meso 5K race and fun run/walk. Firm offices are located in New York City, San Francisco, Los Angeles, St. Louis, and Alton, Illinois. Read more at www.simmonsfirm.com.
